⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Table S1 from The role of protein arginine methyltransferases in pathogenesis and treatment of digestive system carcinoma

Bin Wang Dong Ding Xiaoan Zhang Junxi Zhang Huanhuan Zhang Xinxin Liu Hui Chang Zhan Gao Zengli Yu

View at Publisher

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Table S1 shows the application of PRMT inhibitors in gastrointestinal tumors.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wang et al. (2024) studied this question.

synapsesocial.com/papers/68e58589b6db64358752249d https://doi.org/10.1158/1535-7163.27035923

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S1 from The role of protein arginine methyltransferases in pathogenesis and treatment of digestive system carcinoma2024
2Data from The role of protein arginine methyltransferases in pathogenesis and treatment of digestive system carcinoma2024
3Use of Protein Arginine Methyltransferase Inhibitors in Gliomas2025 · 3 citations
4Current and Emerging Therapies for Targeting Protein Arginine Methyltransferases (PRMTs) in Cancer2025 · 10 citations
5Protein arginine methyltransferase crosstalk: decoding the synergistic-antagonistic axis in cancer therapyReview · 2026

Research Progress on Small-molecule Inhibitors of Protein ArginineMethyltransferase 5 (PRMT5) for Treating Cancer2023
Protein arginine methyltransferases in cancer: mechanisms, functions, and therapeutic opportunities2026
PRMT3 in cancer: arginine methylation as a driver of tumor metabolism, immune evasion, and therapeutic resistance2026